etidronate has been researched along with Carcinoma, Squamous Cell in 4 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Various human tumour cells (such as squamous carcinoma cells and prostate adenocarcinoma cells) and periodontal cells (such as gingival fibroblasts and periodontal ligament cells) were incubated with or without zoledronate and/or etidronate." | 3.79 | In vitro cytotoxicity of zoledronate (nitrogen-containing bisphosphonate: NBP) and/or etidronate (non-NBP) in tumour cells and periodontal cells. ( Dohdoh, M; Endo, Y; Kuroishi, T; Nagai, Y; Ohki, A; Oizumi, T; Sugawara, S; Tanaka, Y, 2013) |
| "Etidronate disodium (EHDP) therapy is often instituted emergently for treatment of hypercalcemia associated with malignancy, and a staging bone scan is part of the evaluation of the patient with extensive metastatic disease." | 3.68 | Skeletal nonvisualization in a bone scan secondary to intravenous etidronate therapy. ( Eary, JF; Hommeyer, SH; Varney, DM, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, Y | 1 |
| Nagai, Y | 1 |
| Dohdoh, M | 1 |
| Oizumi, T | 1 |
| Ohki, A | 1 |
| Kuroishi, T | 1 |
| Sugawara, S | 1 |
| Endo, Y | 1 |
| Nakano, S | 1 |
| Hasegawa, Y | 1 |
| Kajita, A | 1 |
| Nakamura, S | 1 |
| Horai, T | 1 |
| Ikegami, H | 1 |
| Matuda, M | 1 |
| Okamoto, N | 1 |
| Nabeshima, H | 1 |
| Doi, O | 1 |
| Komatubara, Y | 1 |
| Ishigami, S | 1 |
| Hommeyer, SH | 1 |
| Varney, DM | 1 |
| Eary, JF | 1 |
| Ryzen, E | 1 |
| Martodam, RR | 1 |
| Troxell, M | 1 |
| Benson, A | 1 |
| Paterson, A | 1 |
| Shepard, K | 1 |
| Hicks, R | 1 |
4 other studies available for etidronate and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
In vitro cytotoxicity of zoledronate (nitrogen-containing bisphosphonate: NBP) and/or etidronate (non-NBP) in tumour cells and periodontal cells.
Topics: Adenocarcinoma; Annexin A5; Apoptosis; Bone Density Conservation Agents; Carcinoma, Squamous Cell; C | 2013 |
[Clinical studies on the detection of bone metastasis in lung cancer by bone scintigraphy].
Topics: Adenocarcinoma; Adult; Aged; Bone and Bones; Bone Neoplasms; Carcinoma, Small Cell; Carcinoma, Squam | 1983 |
Skeletal nonvisualization in a bone scan secondary to intravenous etidronate therapy.
Topics: Aged; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Carcinoma, Squamous Cell; Drug Interactions; | 1992 |
Intravenous etidronate in the management of malignant hypercalcemia.
Topics: Adult; Aged; Breast Neoplasms; Calcium; Carcinoma, Squamous Cell; Etidronic Acid; Female; Head and N | 1985 |